Premium
Avoiding steroids in pediatric renal transplantation: Long‐term experience from a single centre
Author(s) -
Pedersen Erik Bo,
ElFaramawi Mohamad,
Foged Nils,
Larsen KarlEgon,
Jespersen Bente
Publication year - 2007
Publication title -
pediatric transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.457
H-Index - 69
eISSN - 1399-3046
pISSN - 1397-3142
DOI - 10.1111/j.1399-3046.2007.00731.x
Subject(s) - medicine , immunosuppression , calcineurin , transplantation , surgery , kidney transplantation , tacrolimus , urology
Abstract: We report our experience in pediatric renal transplantation avoiding steroids whenever possible. Immunosuppression consisted of an initial induction with antithymocyte globulin followed by maintenance therapy with a calcineurin inhibitor and MMF. Steroids were only given to selected patients because of the primary disease, recurrence, rejection, or PTLD. Thirty‐four transplants grafted into 32 recipients between 1995 and 2005 were followed for a median of 3.5 yr (range 1–9.8). All patients survived. Graft rejection occurred in 10 cases during the first year post‐transplantation and graft survival at one, five, and seven yr was 97, 88 and 88%, respectively. Steroids were given to half of the patients (n = 16); in nine cases due to rejection. Only four patients (13%) were continuously on steroids. Calculated GFR at one to five yr post‐transplant were 73, 74, 68, 64, and 70 mL/min/1.73 m 2 . Unfortunately PTLD occurred in three patients, but all survived with functioning grafts. Accordingly, our findings indicate that steroid avoidance in pediatric renal transplantation is possible with good results with respect to acute graft rejection as well as long‐term graft survival.